Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Sponsors and Collaborators
Southwest Oncology Group
National Cancer Institute (NCI)
Click here for all study locations and contact info
Edward M. Messing, MD, FACS
James P. Wilmot Cancer Center
David P. Wood, MD
University of Michigan Cancer Center
Next post in Bladder Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.